Nyxoah has recently announced the launch of a study called BREATHE, aimed at examining the real-world impacts of Genio technology on patients with sleep disorders. This study seeks to demonstrate whether real-world evidence can help expedite the adoption of this technology in hospitals and treatment centers.
The Importance of Real-World Evidence in the Adoption of Innovative Technologies
In the medical world, real-world evidence (RWE) is recognized as a powerful tool for assessing the effectiveness and safety of treatments. With this in mind, Nyxoah is looking to gather real data from patients treated with Genio. This data can assist decision-makers in better understanding the real impacts of this technology on patients' sleep quality and life.
Genio, which is a treatment system for sleep disorders, is specifically designed for patients who do not respond to traditional treatments. This technology helps patients achieve better sleep by stimulating specific nerves and preventing side effects associated with traditional treatments.
Challenges and Opportunities in the Path to Genio Adoption
Despite the high potential of Genio, there are challenges in its adoption. Some patients and doctors remain skeptical about this type of treatment and feel the need for stronger evidence to trust this technology. Therefore, the BREATHE study could play a vital role in reducing these doubts and increasing confidence in Genio.
The results of this study, which will be published in the near future, could change the future landscape of therapeutic technologies and show how real-world evidence can facilitate the adoption and use of such treatments. In this regard, Nyxoah, as a leader in providing innovative healthcare solutions, is changing the landscape of sleep disorder treatment.
